SCHEMBL7375035

SCHEMBL7375035

CCOP(=O)(OCC)C(C(=O)NC(=O)c1ccccc1)P(=O)(O)O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
POLB P06746 1/20 0.47
ALDH1A1 P00352 3/20 0.44
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 2/20 0.40
PRSS1 P07477 1/20 0.40
CTSG P08311 1/20 0.40
CTRB1 P17538 1/20 0.40
CMA1 P23946 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PIN1 Q13526 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370159 0.77 SMN1; SMN2 (0.63) SMN1; SMN2POLBALDH1A1GAAKDM4E
SCHEMBL10615983 0.74 SMN1; SMN2 (0.45) SMN1; SMN2POLBKDM4ETDP1MAPT
SCHEMBL11067301 0.73 POLB (0.48) SMN1; SMN2POLBALDH1A1GAATDP1
SCHEMBL8827819 0.71 SMN1; SMN2 (0.63) SMN1; SMN2POLBALDH1A1GAAMAPT
SCHEMBL11062894 0.71 POLB (0.42) SMN1; SMN2POLBALDH1A1GAATDP1
SCHEMBL9449306 0.71 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1GAALMNAKMT2A
SCHEMBL13522913 0.71 ALDH1A1 (0.51) SMN1; SMN2POLBALDH1A1GAAKDM4E
SCHEMBL14377773 0.69 SMN1; SMN2 (0.60) SMN1; SMN2POLBGAACTRB1PIN1
SCHEMBL28888471 0.69 SMN1; SMN2 (0.57) SMN1; SMN2POLBALDH1A1GAAKDM4E
SCHEMBL4047050 0.69 SMN1; SMN2 (0.59) SMN1; SMN2POLBALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5776718-A Reversible protease inhibitors ARRIS PHARMACEUTICAL CORPORATION (US) 1998-07-07 US disclosed
EP-0817778-A1 REVERSIBLE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1998-01-14 EP disclosed
WO-1996030353-A1 REVERSIBLE PROTEASE INHIBITORS ARRIS PHARMACEUTICAL CORPORATION (US) 1996-10-03 WO disclosed